Government gets £74m rebate from pharma
June 30, 2014Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing
The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …
FDA ‘yes’ to inhaled insulin
June 30, 2014Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human
The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …
GSK China sex tape ‘sent to Witty’
June 30, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape
GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …
CHMP approves six drugs including daclatasvir
June 30, 2014Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge
A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …
Quantum Pharmaceutical adds head of commercial
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma
UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …
Value tops the agenda at ASCO cancer conference
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ASCO, Cancer, chicago, mccafferty, oncology
The annual American Society of Clinical Oncology (ASCO) meeting has long been one of the most important events on the …
NICE U-turn on cancer drug despite price increase
June 27, 2014Sales and Marketing Cancer, Glivec, NHS, Novartis, gists
UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …
FDA rejects olaparib
June 27, 2014Sales and Marketing AstraZeneca, Cancer, FDA, PARP, adp, olaparib
AstraZeneca has been dealt a blow by a key advisory committee to the US Food and Drug Administration, which has …
Ranbaxy’s Diovan copycat approved in US
June 27, 2014Manufacturing and Production, Sales and Marketing Diovan, FDA, Novartis, Ranbaxy, blood pressure, sun pharmaceuticals, valsartan
Ranbaxy has won approval for its copycat form of Novartis’ blockbuster blood pressure drug Diovan, as the Swiss firm finally …
BMS expands data transparency
June 27, 2014Medical Communications, Sales and Marketing BMS, best electronic cigarettes, csr, dcri, transparency
Bristol-Myers Squibb is to expand access to its clinical trial data – but researchers’ requests will have to be approved …
Biotec names commercial director
June 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biotec, martin lamb
Clinical trials services firm Biotec Services International has appointed Martin Lamb to the position of commercial director. Lamb will lead …
NICE recommends tenth diabetes drug
June 26, 2014Sales and Marketing Janssen, NHS, diabetes, invokana, type 2
In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …
FDA warns GSK plant
June 26, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, Quebec, flu, flulaval, vaccines
GlaxoSmithKline’s Canadian operation has incurred the displeasure of the US Food and Drug Administration for irregularities in its production of …
Onyx Health launches women’s health blog
June 26, 2014Medical Communications A Snapshot of Women’s Health, Onyx, onyx health, women's blog
Healthcare agency Onyx Health has launched its own blog site and online community dedicated to women’s health. In what the …
AbbVie spells out Shire benefits
June 26, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger
AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …
Retrogenix appoints US director


June 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britz, retrogenix
Biotech firm Retrogenix has appointed Matthew Britz as its North American business development director. Britz will operate out of the …
Review into NHS cover ups
June 25, 2014Sales and Marketing CQC, Francis, Hunt, NHS, UK, robert, whistleblowing
Ministers have ordered a review into the whistleblowing culture within the NHS as it’s announced that 20% of hospitals have …
Willetts champions UK life sciences
June 25, 2014Research and Development, Sales and Marketing BIA, BIO, Steve Bates, UK, Willetts, life sciences, san diego
Science minister David Willetts has been banging the drum for UK life sciences at a major conference in the US, …
Seb Coe: pharma needs to collaborate more
June 25, 2014Medical Communications, Sales and Marketing ABPI, Open Health, olympic, pharma, seb coe
British Olympic Association chair Sebastian Coe has called on pharma firms to participate more in corporate-sponsored disease prevention projects and …
New BMS cancer treatment shines
June 25, 2014Research and Development, Sales and Marketing ASCO, BMS, Cancer, Yervoy, braf, melanoma, nivolumab
Bristol-Myers Squibb’s investigational cancer treatment nivolumab has helped patients with the deadliest form of skin cancer to live longer. The …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
